
Anthropic asks the full appeals court to rehear its Pentagon blacklist case
The designation followed Anthropic's refusal to drop contract bans on lethal autonomous weapons and mass domestic surveillance.
Của The desk, News · · 1 phút đọc
Chịu trách nhiệm: Dimitri Gärtner
Thẻ: anthropic · pentagon · courts · defense
Bài này chưa có bản Tiếng Việt, nên bạn đang đọc tiếng Anh.
- Tin
- The designation followed Anthropic's refusal to drop contract bans on lethal autonomous weapons and mass domestic surveillance.
- Vì sao đáng kể
- Anthropic petitioned the D.C. Circuit for rehearing after a 2-1 panel upheld the Department of War's designation of the company as a supply-chain risk.
- Điều đã được xác nhận
- The photograph is generated for this story.
Gắn với một nguồn được nêu tên. Chưa đánh dấu là đã kiểm chứng. Bloomberg Law
The news
Anthropic on October 13 petitioned the US Court of Appeals for the D.C. Circuit for panel rehearing or rehearing by the full court, challenging a September 25 decision that upheld the Department of War's designation of the company as a national-security supply-chain risk, Bloomberg reported.
Why it matters
The D.C. Circuit has exclusive jurisdiction over this law. The case will decide whether a US agency can blacklist an AI vendor over the conditions it attaches to its models.
The details
The 2-1 ruling, written by Judge Katsas and joined by Judge Rao with Judge Henderson dissenting, treated the department's failure to give notice before the designation as harmless. Anthropic argues the panel misread the statute, wrongly excused the skipped notice and failed to find retaliation for its public AI-safety stance.
The designation followed Anthropic's refusal in February to drop contract terms barring use of Claude for lethal autonomous weapons and mass domestic surveillance.
What we could not check
- We did not read the petition itself, only reporting and summaries.
- The department's response is not yet public.
Nguồn
The photograph is generated for this story. It does not show the people named in it.